Navigation Links
KV Pharmaceutical Receives Stockholder Action by Written Consent
Date:9/15/2009

mpact of the recall and suspension of shipments on revenues, and other financial results, are forward-looking statements.

All forward-looking statements are based on current expectations and are subject to risk and uncertainties. In connection with the "safe harbor" provisions, the Company provides the following cautionary statements identifying important economic, political and technological factors, which among others, could cause actual results or events to differ materially from those set forth or implied by the forward-looking statements and related assumptions.

Such factors include (but are not limited to) the following: (1) the ability to continue as a going concern; (2) changes in the current and future business environment, including interest rates and capital and consumer spending; (3) the difficulty of predicting FDA approvals, including timing, and that any period of exclusivity may not be realized; (4) the possibility of not obtaining FDA approvals or delay in obtaining FDA approvals; (5) acceptance and demand for new pharmaceutical products; (6) the introduction and impact of competitive products and pricing, including as a result of so-called authorized-generic drugs; (7) new product development and launch, including the possibility that any product launch may be delayed or that product acceptance may be less than anticipated; (8) reliance on key strategic alliances; (9) the availability of raw materials and/or products manufactured for the Company under contract manufacturing arrangements with third parties; (10) the regulatory environment, including regulatory agency and judicial actions and changes in applicable law or regulations; (11) fluctuations in revenues; (12) the difficulty of predicting international regulatory approvals, including timing; (13) the difficulty of predicting the pattern of inventory movements by the Company's customers; (14) the impact of competitive response to the Company's sales, mar
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Texas (PRWEB) May 06, 2015 ... of the HIMSS EMR Adoption Model, the hospital ... improve patient engagement and automate processes. The leadership ... from paper-driven to electronic workflows, patient registration still ... copies of consents. With HIMSS Stage 7 attestation ...
(Date:5/6/2015)... A quality built chicken coop condo with a wheel kit ... raise chickens on a pasture. By installing a wheel kit ... a chicken tractor that stands up to being moved around the ... is able to flex to uneven ground without losing its shape. ... fertilized, and it will help provide the chickens with fresh foraging ...
(Date:5/6/2015)... Experienced Vancouver air conditioning installation and ... they will now conduct their cooling services, including air ... to commercial and residential units. Strata complex air conditioning ... of technical knowledge as well as a professionally trained ... will take away any old air conditioning unit to ...
(Date:5/6/2015)... May 06, 2015 Chesapeake Regional ... state of Virginia to acquire Intuitive Surgical, Inc.’s ... The system upgrade includes enhanced surgical technique capabilities, ... procedures across a wide spectrum of specialties. Its ... pain and quicker recovery times. , “As the ...
(Date:5/6/2015)... North Vancouver, BC (PRWEB) May 06, 2015 ... leading colon hydrotherapy supplier, is excited to announce ... which will help reduce the industry’s carbon footprint ... These kits feature Eco-Flex™, the ... hydrotherapy. “This is a game-changer for hydrotherapists,” claims ...
Breaking Medicine News(10 mins):Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 2Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 3Health News:Chicken Coop Condo Launches the Chicken Tractor 2Health News:Pro Ace Care Now Does Air Conditioning Installation for Strata Complexes 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 3Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3
... antiretroviral therapy (ART) immediately to those found infected with the ... in the New England Journal of Medicine . The ... an average age of 7 weeks made them four times ... with postponing ART until signs of illness or a weakened ...
... Resource Institute Gives Atria Senior Living Honorable Mention While Atria ... LOS ANGELES, Nov. 19 On Nov. 17, ... announced the winners of its "2008 Great California Workplaces Award," ... country,s largest assisted living providers. , ...
... such as obesity, are just as useful, studies find , , ... gene variations associated with type 2 diabetes was no better ... than a doctor,s assessment, researchers report. , The news is ... You can be tested for disease risk," said Dr. James ...
... ARAY ), a global leader in the field of ... a notice from the Nasdaq Stock,Market stating that it is ... because the Company has not timely filed its Report on ... Within 60 calendar days ...
... WASHINGTON, Nov. 19 Scott P. Serota, President and Chief ... (BCBSA), released the following statement: , ... Shield companies have been steadfast champions of comprehensive healthcare reform ... and to improve quality throughout the entire system. We are ...
... 19 Recognizing November 20th as the 33rd Great ... National Community Pharmacists Association House of Delegates has approved ... from selling tobacco products in their pharmacies. , ... for helping their patients to maintain good health and ...
Cached Medicine News:Health News:Landmark study defines benefits of early HIV testing and treatment for infected infants 2Health News:Landmark study defines benefits of early HIV testing and treatment for infected infants 3Health News:'Great California Workplace Award' Goes to Company Facing Lawsuits, Possible Federal Complaint 2Health News:Genetic Testing No Real Help in Predicting Type 2 Diabetes 2Health News:Genetic Testing No Real Help in Predicting Type 2 Diabetes 3Health News:Accuray Receives Nasdaq Notification Related to the Late Filing of Form 10-Q 2Health News:Accuray Receives Nasdaq Notification Related to the Late Filing of Form 10-Q 3Health News:Accuray Receives Nasdaq Notification Related to the Late Filing of Form 10-Q 4Health News:BCBSA Announces Support for Individual Mandate Coupled With a Requirement for Insurers to Offer Coverage to All 2Health News:NCPA Encourages Member Pharmacists to Consider Refraining From Selling Tobacco Products 2
(Date:5/6/2015)... May 6, 2015  CTI BioPharma Corp. (NASDAQ and ... quarter ended March 31, 2015. ... 3 clinical trial of pacritinib during the quarter, we ... treating physicians who are excited by the potential opportunity ... in the treatment of patients with myelofibrosis, specifically in ...
(Date:5/6/2015)... PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ... ended March 31, 2015. Total revenues for ... $149.7 million from $136.8 million in the first quarter ... 2015 included $127.8 million in royalty and license payments ... $11.4 million in net royalty payments from acquired royalty ...
(Date:5/6/2015)... 6, 2015  Integrative medicine interventions lead to ... for chronic pain, depression, and stress, according to ... The Bravewell Collaborative . The findings are based ... Medicine Interventions Effectiveness Registry (PRIMIER), the first-ever patient ... from PRIMIER , researchers found that the ...
Breaking Medicine Technology:CTI BioPharma Reports First Quarter 2015 Financial Results 2CTI BioPharma Reports First Quarter 2015 Financial Results 3CTI BioPharma Reports First Quarter 2015 Financial Results 4CTI BioPharma Reports First Quarter 2015 Financial Results 5CTI BioPharma Reports First Quarter 2015 Financial Results 6CTI BioPharma Reports First Quarter 2015 Financial Results 7CTI BioPharma Reports First Quarter 2015 Financial Results 8CTI BioPharma Reports First Quarter 2015 Financial Results 9PDL BioPharma Announces First Quarter 2015 Financial Results 2PDL BioPharma Announces First Quarter 2015 Financial Results 3PDL BioPharma Announces First Quarter 2015 Financial Results 4PDL BioPharma Announces First Quarter 2015 Financial Results 5PDL BioPharma Announces First Quarter 2015 Financial Results 6PDL BioPharma Announces First Quarter 2015 Financial Results 7Integrative Medicine has Positive Impact on Patient Activation, Chronic Pain, Depression 2
... Greenville, SC, announced today that its Glucommander™ 2.0 Enterprise software ... 2 - 17. Glytec,s Glucommander was the first insulin dosing ... it is the only company to achieve specific ... company cleared to offer this technology to hospitals caring for ...
... OLATHE, Kan., May 21, 2012  BD (Becton, Dickinson and ... medical technology company, and Heart to Heart International, a ... their second joint volunteer initiative to strengthen healthcare in ... the world will build upon the progress made by ...
Cached Medicine Technology:Glytec Adds Pediatric Insulin Dosing to its IV and SubQ FDA Clearances 2BD and Heart to Heart International Collaborate on Second Volunteer Service Trip to Help Improve Healthcare in Haiti 2BD and Heart to Heart International Collaborate on Second Volunteer Service Trip to Help Improve Healthcare in Haiti 3
An enzyme linked immunosorbent assay (ELISA) for the detection and quantitationof RF IgG isotype in human serum of patients with rheumatoid arthritis....
An enzyme linked immunosorbant assay (ELISA) for the detection and quantitation of Rheumatoid Factor (RF) of IgM isotype in human serum....
An enzyme linked immunoassay (ELISA) for the detection and semiquantitationof IgG and IgM antibodies to 2-GP1, as an aid in assessingthe risk of thrombosis in patients with Systemic Lupus Erythematos...
An enzyme linked immunoassay (ELISA) for the detection and semiquantitation of IgG, IgA or IgM anticardiolipin antibodies, as an aid in assessing the risk of thrombosis in individuals with Systemic L...
Medicine Products: